First-in-Human, Single- and Multiple-Ascending-Dose, Food-Effect, and Absolute Bioavailability Trials to Assess the Pharmacokinetics, Safety, and Tolerability of Pritelivir, a Nonnucleoside Helicase-Primase Inhibitor Against Herpes Simplex Virus in Healthy Subjects.
Clin Pharmacol Drug Dev
; 12(7): 749-760, 2023 07.
Article
in En
| MEDLINE
| ID: mdl-36860173
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Simplexvirus
/
DNA Primase
Limits:
Female
/
Humans
/
Male
Language:
En
Journal:
Clin Pharmacol Drug Dev
Year:
2023
Document type:
Article
Affiliation country:
Alemania